HON
67
2
MLM
57
6
CPB
30
6
ORLY
62
2
NWS
66
-3
HCP
66
8
CSCO
67
4
DE
63
3
CFG
70
6
NSC
60
3
EXC
53
-3
VTR
47
-7
KMI
67
-2
UA
50
-9
NVDA
56
-4
NRG
49
-3
IBM
58
-2
BK
74
2
WEC
53
-2
NAVI
52
5
HON
67
2
MLM
57
6
CPB
30
6
ORLY
62
2
NWS
66
-3
HCP
66
8
CSCO
67
4
DE
63
3
CFG
70
6
NSC
60
3
EXC
53
-3
VTR
47
-7
KMI
67
-2
UA
50
-9
NVDA
56
-4
NRG
49
-3
IBM
58
-2
BK
74
2
WEC
53
-2
NAVI
52
5
Financhill
Back

Cybin Vs. Aurinia Pharmaceuticals Industry Stock Comparison

Buy
51

CYBN
Cybin

Last Price:
9.68
Seasonality Move:
25.56%
Buy
79

AUPH
Aurinia Pharmaceuticals

Last Price:
8.88
Seasonality Move:
24.51%
Buy
51
Cybin (CYBN) is a Buy

Is Cybin a Buy, Sell or Hold?

  • The current Cybin [CYBN] share price is $9.82. The Score for CYBN is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
  • CYBN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
79
Aurinia Pharmaceuticals (AUPH) is a Buy

Is Aurinia Pharmaceuticals a Buy, Sell or Hold?

  • The current Aurinia Pharmaceuticals [AUPH] share price is $8.86. The Score for AUPH is 79, which is 58% above its historic median score of 50, and infers lower risk than normal.
  • AUPH is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

CYBN Stock Price Chart

What is Cybin's stock price today?

  • The Cybin share price today is $9.82
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CYBN is experiencing slight buying pressure.

AUPH Stock Price Chart

What is Aurinia Pharmaceuticals's stock price today?

  • The Aurinia Pharmaceuticals share price today is $8.86
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AUPH is experiencing slight buying pressure.

CYBN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.12 Buy
Relative Strength Index (14 RSI): 44.65 Sell
Chaikin Money Flow: 112272 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (10.1 - 11.3) Sell
Bollinger Bands (100): (8.98 - 11.12) Sell

AUPH Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.37 Buy
Relative Strength Index (14 RSI): 72.92 Buy
Chaikin Money Flow: 122744 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (7.17 - 8.37) Buy
Bollinger Bands (100): (5.81 - 7.63) Buy

CYBN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 10.73 Sell
20-day SMA: 10.65 Sell
50-day SMA: 10.02 Sell
200-day SMA: 11.77 Sell
8-day EMA: 10.6 Sell
20-day EMA: 10.63 Sell
50-day EMA: 10.32 Sell
200-day EMA: 11.61 Sell

AUPH Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 8.34 Buy
20-day SMA: 7.95 Buy
50-day SMA: 7.43 Buy
200-day SMA: 6.09 Buy
8-day EMA: 8.41 Buy
20-day EMA: 8.03 Buy
50-day EMA: 7.49 Buy
200-day EMA: 6.84 Buy

Cybin Earnings Growth & CYBN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $6.40 per share, and a decrease next year of $3.04 per share.

Aurinia Pharmaceuticals Earnings Growth & AUPH Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.12 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.55 per share, and an increase next year of $0.54 per share.

Cybin Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Aurinia Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):